Cite
HARVARD Citation
Biemond, B. et al. (2021). Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 8 (5), pp. e334-e343. [Online].